Karadurmus, N. Et Al. 2017. Effectiveness of bendamustine in relapse or refractory lymphoma cases: A report from Turkey-The Turkish Oncology Group (TOG) study.. 53rd Annual Clinical Meeting of the American-Society-of-Clinical-Oncology (ASCO) , (Illinois, United States Of America).

Karadurmus, N., Paydas, S., Ocal, R., Yildiz, B., Nayir, E., Dogan, M., ... Sumbul, A. T.(2017). Effectiveness of bendamustine in relapse or refractory lymphoma cases: A report from Turkey-The Turkish Oncology Group (TOG) study. . 53rd Annual Clinical Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America

Karadurmus, Nuri Et Al. "Effectiveness of bendamustine in relapse or refractory lymphoma cases: A report from Turkey-The Turkish Oncology Group (TOG) study.," 53rd Annual Clinical Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 2017

Karadurmus, Nuri Et Al. "Effectiveness of bendamustine in relapse or refractory lymphoma cases: A report from Turkey-The Turkish Oncology Group (TOG) study.." 53rd Annual Clinical Meeting of the American-Society-of-Clinical-Oncology (ASCO) , Illinois, United States Of America, 2017

Karadurmus, N. Et Al. (2017) . "Effectiveness of bendamustine in relapse or refractory lymphoma cases: A report from Turkey-The Turkish Oncology Group (TOG) study.." 53rd Annual Clinical Meeting of the American-Society-of-Clinical-Oncology (ASCO) , Illinois, United States Of America.

@conferencepaper{conferencepaper, author={Nuri Karadurmus Et Al. }, title={Effectiveness of bendamustine in relapse or refractory lymphoma cases: A report from Turkey-The Turkish Oncology Group (TOG) study.}, congress name={53rd Annual Clinical Meeting of the American-Society-of-Clinical-Oncology (ASCO)}, city={Illinois}, country={United States Of America}, year={2017}}